Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023

Image
pediatrics associates of dallas :: Article Creator Pediatric Diagnostic Associates Will Continue Serving Families As A Practice Independent Of CHI Memorial Pediatric Diagnostic Associates, which was previously associated with CHI Memorial Hospital, announced Thursday it will again become an independent practice under newly formed Scenic City Pediatrics PLLC. Effective Feb. 1, the medical group will enter a new contract with BlueCross BlueShield of Tennessee, including Networks P and S, among other insurers, according to a news release. The change follows a June decision on BlueCross BlueShield of Tennessee's behalf to terminate its contract with Memorial relating to its Network S customers. Managing Partner Dr. Tony Friddell said in a phone interview Pediatric Diagnostic Associates has been under the CHI Memorial umbrella as a managed practice within the hospital system for 28 years. In some shape or form, Pediatric Diagnostic Associates...

Anglo-Chinese research suggests pancreatic cancer vaccine is possible - The Pharma Letter

Researchers from Queen Mary University of London and Zhengzhou University, China, have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer, they believe.

Newly-published research provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.

Survival time doubled

The study reports the team's work with a pre-clinical model using mice. The research was published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Researchers created a vaccine system that doubled the survival time of mice with pancreatic cancer. Importantly, the vaccine system can be personalized for the individual receiving it and could potentially be tailored to work against other types of cancer.

'Could be a platform for developing personalized and powerful cancer vaccines'

Yaohe Wang from Queen Mary University of London and the Sino-British Research Centre at Zhengzhou University in China, who led the study, said: “Development of a preventive vaccine against non-viral cancers is hugely limited by the lack of appropriate tumor antigens and an effective approach to induce robust anti-tumor immunity against those antigens.

“Through this international collaboration, we have made progress towards the development of a prophylactic cancer vaccine against pancreatic cancer.

“This is preliminary data from tests on mice but it could be a platform for developing personalized and powerful cancer vaccines to reduce cancer incidence in at-risk individuals.”

Louisa Chard Dunmall, senior postdoctoral research fellow at Queen Mary, said: “Although this research is at the early developmental stages, it provides strong evidence that the creation of a vaccine against pancreatic cancer is possible.”



https://ift.tt/37JMsks

Comments

Popular posts from this blog

These Are the Top Doctors in the Hudson Valley in 2022

William Buoni, MD - Wexner Medical Center

Who are the top doctors in Columbus? Search by specialty with Columbus Monthly's 2021 list